Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

OCW Rutherford, C Jonasson… - European Heart …, 2020 - academic.oup.com
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
被引用次数：87 相关文章

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

OCW Rutherford, C Jonasson… - European heart …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
[PDF] oup.com

[PDF][PDF] Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

OCW Rutherford, C Jonasson… - European Heart …, 2020 - academic.oup.com
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
[PDF] unit.no

[PDF][PDF] Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study

OCW Rutherford, C Jonasson, WK Ghanima… - 2020 - fhi.brage.unit.no
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial
fibrillation: a nationwide cohort stu Page 1 ........................ Comparison of dabigatran …

Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study

OCW Rutherford, C Jonasson, WK Ghanima… - … Heart Journal (EHJ) …, 2020 - duo.uio.no
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major
bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and apixaban …

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

OCW Rutherford, C Jonasson… - European Heart …, 2020 - search.proquest.com
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study.

OCW Rutherford, C Jonasson, W Ghanima… - European Heart …, 2020 - go.gale.com
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
[HTML] nih.gov

[HTML][HTML] Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

OCW Rutherford, C Jonasson, W Ghanima… - European Heart …, 2020 - ncbi.nlm.nih.gov
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study.

OW Rutherford, C Jonasson, W Ghanima… - European Heart …, 2020 - europepmc.org
AIMS: The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …

Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study

OCW Rutherford, C Jonasson, WK Ghanima… - 2020 - ntnuopen.ntnu.no
The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major
bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and apixaban …